Welcome to LookChem.com Sign In|Join Free

CAS

  • or

401791-55-7

Post Buying Request

401791-55-7 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

401791-55-7 Usage

Structure

Benzimidazole derivative with a carboxylic acid group and a methoxy group

Explanation

The compound is derived from benzimidazole, which is a heterocyclic compound containing a benzene ring fused to an imidazole ring. It has a carboxylic acid group (-COOH) and a methoxy group (-OCH3) attached to it.

Explanation

A heterocyclic compound is a cyclic compound containing atoms of different elements, in this case, carbon, nitrogen, and oxygen. The benzene ring is fused to an imidazole ring, forming the core structure of the compound.

Explanation

Benzimidazoles and their derivatives have been found to exhibit various biological activities, which may include fighting cancer, reducing inflammation, and combating viral infections. However, the specific properties and potential applications of this particular compound would depend on further research and testing.

Explanation

The IUPAC name (International Union of Pure and Applied Chemistry) is a standardized way of naming chemical compounds. In this case, the name indicates that the compound is a benzimidazole derivative with a carboxylic acid group at the 5-position and a methoxy group at the 2-position.

Explanation

The CAS Registry Number is a unique identifier assigned to every chemical substance. The 9CI prefix indicates that this compound is a derivative of benzimidazole with specific functional groups.

Explanation

While benzimidazoles and their derivatives have shown diverse biological activities, the specific properties and potential applications of 1H-Benzimidazole-5-carboxylic acid, 2-methoxy-(9CI) would need to be investigated through additional research and testing to fully understand its potential uses and effectiveness.

Heterocyclic compound

Contains a benzene ring fused to an imidazole ring

Biological activities

Potential anti-cancer, anti-inflammatory, and anti-viral properties

CAS Registry Number

9CI (Chemical Abstracts Service)

Further research and testing

Required to determine specific properties and potential applications

Check Digit Verification of cas no

The CAS Registry Mumber 401791-55-7 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 4,0,1,7,9 and 1 respectively; the second part has 2 digits, 5 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 401791-55:
(8*4)+(7*0)+(6*1)+(5*7)+(4*9)+(3*1)+(2*5)+(1*5)=127
127 % 10 = 7
So 401791-55-7 is a valid CAS Registry Number.

401791-55-7SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 18, 2017

Revision Date: Aug 18, 2017

1.Identification

1.1 GHS Product identifier

Product name 2-Methoxy-1H-benzimidazole-5-carboxylic acid

1.2 Other means of identification

Product number -
Other names 11H-Pyrido(2,1-b)quinazoline-8-carboxylic acid,2-methoxy-11-oxo

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:401791-55-7 SDS

401791-55-7Downstream Products

401791-55-7Relevant articles and documents

NOVEL CC-1065 ANALOGS AND THEIR CONJUGATES

-

Page/Page column 147, (2010/06/17)

This invention relates to novel analogs of the DNA-alkylating agent CC-1065 and to their conjugates. Furthermore this invention concerns intermediates for the preparation of said agents and conjugates. The conjugates are designed to release their (multiple) payload after one or more activation steps and/or at a rate and time span controlled by the conjugate in order to selectively deliver and/or controllably release one or more of said DNA alkylating agents. The agents, conjugates, and intermediates can be used to treat an illness that is characterized by undesired (cell) proliferation. As an example, the agents and the conjugates of this invention may be used to treat a tumor.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 401791-55-7